Literature DB >> 6813961

The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.

B Osterud, E Bjørklid.   

Abstract

These studies were undertaken to determine the type and availability of the procoagulant activities generated in blood incubated with endotoxin. The shortening of the recalcification time of blood incubated with endotoxin was directly correlated with the increase in synthesis of tissue thromboplastin in the monocytes. The procoagulant activity which resulted in the shortening of the clotting time was shown to be almost totally blocked by tissue thromboplastin antibodies. Thus, no additional procoagulant activity was generated in platelets during the 5 h incubation of blood with endotoxin. However, lysed platelets enhanced the synthesis of tissue thromboplastin in blood monocytes in the presence of endotoxin. Lysed red blood cells or granulocytes had no such effect. In endotoxin stimulated monocytes the main part of the newly synthesized tissue thromboplastin appeared to be exposed on the cellular surface. Thus, only 25% of the tissue thromboplastin activity was recovered when tissue thromboplastin antibodies had been present during the stimulation. Unstimulated monocytes were also found to possess tissue thromboplastin activity, but this low activity was not affected by tissue thromboplastin antibodies unless the monocytes were disrupted by sonication. The high percentage of tissue thromboplastin exposed on the surface of the endotoxin stimulated monocytes in whole blood may contribute significantly to the rapid induction of disseminated intravascular coagulation in gram negative sepsis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813961     DOI: 10.1111/j.1600-0609.1982.tb00580.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  19 in total

1.  Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

Authors:  R Lorenzet; J Niemetz; A J Marcus; M J Broekman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Contribution of the monocyte to thrombotic potential.

Authors:  C R Spillert; E J Lazaro
Journal:  Agents Actions       Date:  1991-09

3.  Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.

Authors:  M Saliola; R Lorenzet; D Ferro; S Basili; C Caroselli; A D Santo; M Sallese; F Violi
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

4.  P-selectin induces the expression of tissue factor on monocytes.

Authors:  A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Recalcification time in breast disease.

Authors:  C A Sofia; C R Spillert; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

6.  Altered coagulability: an aid to selective breast biopsy.

Authors:  C R Spillert; M R Passannante; J E Salzer-Pagan; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

7.  Thromboplastin (tissue factor) in plasma membranes of human monocytes.

Authors:  O Hetland; A B Brovold; R Holme; G Gaudernack; H Prydz
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

8.  Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability.

Authors:  Elena M Egorina; Mikhail A Sovershaev; Geir Bjørkøy; Franz X E Gruber; Jan O Olsen; Behnaz Parhami-Seren; Kenneth G Mann; Bjarne Østerud
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-28       Impact factor: 8.311

9.  Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.

Authors:  C R Spillert; S Sun; M A Miller; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

10.  Induction of procoagulant activity in human leukocytes with lipoglycans from mycoplasmas.

Authors:  G Miragliotta; G Barone; R A Monno; D Fumarola; P F Smith
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.